LabCorp is widening availability of its antibody test to detect exposure to the coronavirus

Indonesia Berita Berita

LabCorp is widening availability of its antibody test to detect exposure to the coronavirus
Indonesia Berita Terbaru,Indonesia Berita utama
  • 📰 CNBC
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 72%

LabCorp also was granted FDA approval this week for its at-home test for Covid-19.

The so-called serology tests are "for patients that don't have symptoms, that do not currently have Covid-19 but believe they've had it in the past," Schechter said onSchechter said that people will be able to access the blood tests through their physicians and urgent care clinics as well as through telemedicine services.

Schechter said that LabCorp has validated the test and believes it is "extremely accurate" in detecting whether someone has antibodies for Covid-19. However, he stressed it's too early to determine the exact benefits of having the antibodies. Dr. Scott Gottlieb, the former commissioner of the Food and Drug Administration, told CNBC on Wednesday that expectations around serology tests should be tempered.

Berita ini telah kami rangkum agar Anda dapat membacanya dengan cepat. Jika Anda tertarik dengan beritanya, Anda dapat membaca teks lengkapnya di sini. Baca lebih lajut:

CNBC /  🏆 12. in US

Indonesia Berita Terbaru, Indonesia Berita utama

Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.

Coronavirus live updates: FDA greenlights first test with at-home sample, Trump targets immigrationCoronavirus live updates: FDA greenlights first test with at-home sample, Trump targets immigration“We have to get going. We have to move forward,” Starwood Capital’s Barry Sternlicht said today. “The cost is too great. The government cannot carry a $23 trillion economy.”
Baca lebih lajut »

FDA greenlights first coronavirus test with at-home sample, Trump targets immigrationFDA greenlights first coronavirus test with at-home sample, Trump targets immigrationThe number of coronavirus cases in the U.S. is probably 10x higher than the number we’ve diagnosed, Dr. Scott Gottlieb said. “There’s certainly underdiagnosis going on.”
Baca lebih lajut »

FDA Authorizes First At-Home Coronavirus Self-Swab Test—But It Won't Be Available to EveryoneFDA Authorizes First At-Home Coronavirus Self-Swab Test—But It Won't Be Available to EveryoneThe test from LabCorp will initially only be available to health care workers and first responders under a doctor's orders
Baca lebih lajut »

FDA authorizes first at-home coronavirus testFDA authorizes first at-home coronavirus testLabCorp's home collection test to diagnose coronavirus infection will be made available to consumers in most states over the next few weeks.
Baca lebih lajut »

FDA greenlights first coronavirus test with at-home sample collectionFDA greenlights first coronavirus test with at-home sample collectionRegulators at the U.S. Food and Drug Administration on Tuesday authorized the first coronavirus test that lets people collect a sample at home.
Baca lebih lajut »

Coronavirus cases are likely 10 to 20 times higher in US than reported, former FDA chief Gottlieb saysCoronavirus cases are likely 10 to 20 times higher in US than reported, former FDA chief Gottlieb saysHealth experts say there needs to be much more Covid-19 testing to better monitor the spread of coronavirus as states seek to reopen businesses and social settings
Baca lebih lajut »



Render Time: 2025-03-13 11:55:38